102 results
Page 2 of 6
8-K
EX-99.1
1fvf0x8bh 7xtwwzrh
1 Oct 20
Contingent Value Rights Agreement
8:42am
8-K
EX-10.4
1uql 6dok5e
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
vkgjdbmv0tov9kt5h
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
6ae4nfnr
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-C
EX-99.2
ug42o1izy6 l8m1
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-99.2
9vbp1gxl
10 Aug 20
Tender and Support Agreement
9:48pm
8-K
EX-99.1
xr40aml8khxt231
6 May 20
Ligand Reports First Quarter 2020 Financial Results
4:03pm
8-K
EX-99.1
drcbj
2 Apr 20
Ligand Completes Acquisition of Icagen Core Assets, Partnered Programs
4:18pm
8-K
EX-99.1
2iefhjemr0
5 Mar 19
Entry into a Material Definitive Agreement
5:16pm
8-K
8s7m2yzfkyzg
5 Mar 19
Entry into a Material Definitive Agreement
5:16pm